Related Experiment Video
Updated: Jan 8, 2026
09:46
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
20.4K
Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming
Estelle Carminita1,2, Virginia Camacho1,2, Siobhan Branfield1,2
1Vascular Biology Program, Boston Children's Hospital, Boston, MA.
Blood Advances
|December 18, 2025
Summary
Chronic kidney disease (CKD) causes platelet dysfunction through bone marrow changes and harmful factors. Targeting bone marrow pathology may reduce cardiovascular risk in CKD patients.
Area of Science:
- Hematology
- Nephrology
- Cardiovascular Medicine
Background:
- Chronic kidney disease (CKD) increases thrombotic event risk.
- Platelet dysfunction in CKD is not fully understood, with limited focus on bone marrow.
- Previous research focused on uremic toxins, overlooking megakaryocyte (MK) biology.
Purpose of the Study:
- Investigate CKD's impact on megakaryopoiesis and platelet production.
- Explore the role of the bone marrow microenvironment in CKD-related platelet abnormalities.
- Identify mechanisms driving platelet hyperreactivity in CKD.
Main Methods:
- Induced CKD in a murine model using aristolochic acid (AA).
- Analyzed kidney function, bone marrow cellularity, and MK density.
- Performed proteomic analysis of CKD-derived MKs.
- Assessed proplatelet formation in vitro and platelet reactivity in vivo.
Main Results:
- CKD mice showed kidney dysfunction, anemia, and decreased MK density.
- CKD-derived MKs had altered proteomic signatures related to metabolic stress.
- Bone marrow supernatant from CKD mice promoted proplatelet formation.
- CKD platelets exhibited hyperreactivity, increased aggregation, and degranulation.
Conclusions:
- CKD induces platelet dysfunction via intrinsic MK reprogramming and extrinsic bone marrow factors.
- Findings highlight the bone marrow microenvironment's role in CKD platelet abnormalities.
- Targeting bone marrow pathology could mitigate cardiovascular risk in CKD patients.
Related Concept Videos
01:18Structure and Function of Platelets
2.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
2.8K
01:25Chronic Kidney Disease I: Introduction
541
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
541
01:24Chronic Kidney Disease II: Clinical Manifestations
522
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
522
01:28Chronic Kidney Disease III: Interprofessional Care
320
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
320
01:20Renal Corpuscle
6.8K
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
6.8K
01:40Bone Remodeling
40.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
40.2K